Earlier this year, Akorn Pharmaceuticals fell into bankruptcy, and now an alliance of stakeholders have released a report outlining potential supply disruption to a number of medications.
The company will build out a manufacturing, warehousing, and distribution center in the US to expand capacity for syringes.
This capsule of industry news features Amcor, High Purity New England, MG America, and other firms offering packaging and labeling products and services.
The temporary medicines unit built for the agency's Central Intravenous Additive Service can produce up to 2,600 syringes weekly to meet growing demand
The contract pharmaceutical packaging firm plans to add automated packaging equipment to help meet growing demand for pre-filled syringes and vials.
While the prevalence of chronic diseases boosts the demand for self-administered treatments, ease of use is becoming more important in device manufacturing, says product specialist.
UK MHRA publishes a drug alert regarding delivery failure in Emerade adrenaline syringes indicated for anaphylaxis.
Fresenius Kabi voluntarily recalled 163 lots of sodium chloride injections, after the presence of latex was found within its packaging.
Aptar Pharma has formed an alliance with Becton, Dickinson & Co to develop new self-injection devices that will tap into the strong growth in injectable drugs.
Hikma invested over $25m in its US facilities in the first half 2016, and plans to use excess capacity at a former Boehringer Ingelheim plant for contract manufacturing.
Fresenius Kabi and a UK drug manufacturer have been sentenced for supplying faulty insulin syringes which contributed to a diabetic man’s death.
Aesica has started expanding capacity at its pre-filled syringe plant in the UK after predicting a surge in demand.
BD says its new quality by design glass prefillable syringe offers added safety in delivering biologics as the industry continues to shift toward biotechnology.
API maker ScinoPharm is to invest in cancer drug and injectables capacity, citing current global shortages as a driver for its decision.
West inks pre-filled syringe deal with Vetter
Injectable drug delivery systems maker West has struck a new joint venture with Vetter to provide source filled Daikyo Crystal Zenith syringes.
Circassia and NanoPass strike up deal over intradermal device
Immunotherapy and vaccine specialist Circassia says its new license agreement with NanoPass Technologies will help its range of allergy products to thrive on the market.
West says Crystal Zenith syringe is solution to pharmas' glass delamination problem
West Pharmaceutical Services is preparing to increase its manufacturing capacity in response to an increased demand for its Daikyo Crystal Zenith 1mL syringe system.
USDA backs Unilife’s US HQ construction
Unilife wins US Department of Agriculture (USDA) as guarantor for new manufacturing facility and global headquarters in York, Pennsylvania, US.
AMRI buys Hyaluron to enter prefilled syringe market
AMRI has acquired Hyaluron for $27m (€22m) to enter the prefilled syringe market and expand the customer base for its existing operations.
Unilife starts 24/7 production after FDA marketing clearance
Unilife has initiated a 24/7 manufacturing cycle at its facility at Lewisberry, Pennsylvania, US after it received marketing clearance for its Unitract 1ml insulin syringes from the US FDA.
Nipro recalls GlucoPro insulin syringes
Nipro Medical has recalled all batches of its GlucoPro insulin syringes in the US after discovering that the needles could detach during use.
Qualitest expands recall to all Accusure insulin syringes
US generics firm Qualitest Pharmaceuticals has recalled all Accusure insulin syringes after reports that the needles may detach from the syringe.
Schott plans 24/7 RTF syringe production at US plant
The US arm of packaging giant Schott has added ready-to-fill (RTF) glass syringe manufacturing capacity at its facility in Lebanon, Pennsylvania in a $14m (€9.4m) expansion designed to meet growing demand.
Covidien recalls mislabelled insulin syringes
Covidien is recalling half a million ReliOn single-use insulin syringes after it was uncovered that some had been mislabelled, creating the potential for fatal overdose.
West syringe to minimise leachables
West has launched the first silicone-oil-free, prefillable syringe,
which minimises the quantity of leachables in the pharmaceutical
Helvoet burns rubber to stay ahead of injectables market
The world's number two manufacturer of rubber components for
pharmaceutical products, Helvoet Pharma, has broken ground on a new
facility that promises to double or even triple its capacity to
supply the fast-growing markets...
New syringe-testing rig launched
A new syringe-testing rig has been launched by texture analysis
equipment provider, Stable Micro Systems.
Gerresheimer announces latest plastics plans
Gerresheimer has announced it will launch a new plastic syringe
range in January to cater for highly-sensitive medications and also
for high-volume injections.
European inhaled insulin market to explode
The convenience of non-invasive insulin delivery methods is set to
overcome their high cost and concerns about safety and efficacy,
with the greatest beneficiary being the European inhaled insulin
market which is predicted to swell...
West profits surge; Exubera contract gains momentum
West Pharmaceutical Services has reported a huge surge in both
sales and profits for its second quarter, spurred on by the
increasing demand for injectable drugs as well as the lucrative
Exubera manufacturing contract, which helped...
Insulin delivery devices - an industry under threat
In-PharmaTechnologist insulin series
The insulin delivery devices thriving in today's market will slowly
be replaced as new and better technologies continue to rise from
the R&D pipeline. For current market leader, Novo Nordisk, this
threat is particularly dangerous.
Demand growing for pre-fillable syringes
The Parenteral Drug Association (PDA) recently held a conference in
Munich to fuel the further development of the growing pre-fillable
Patent on low-cost safety syringe filed
A patent covering a simple design for a safety syringe, which uses
a vacuum rather than a spring to retract the needle after use and
should be cheaper to manufacture than current products, has been
filed in the US by Maxxon Inc.
Gerresheimer rolls out new lines at Interpack
Gerresheimer launched a crop of new pharmaceutical components at
the Interpack show last week, including a new system for the dosing
of water-soluble dry medications and new devices to improve the
safety and ease of use of its syringe...
Safety syringes booming
The market for retractable syringes designed to prevent needlestick
injuries is set for explosive growth and could expand nearly
seven-fold by 2006, according to a new report.